Brief: Novartis BidCo Germany plans merger squeeze-out of Morphosys minority shareholders
20/06/2024 07:14
June 20 (Reuters) - MORPHOSYS AG MORG.DE :
* NOVARTIS BIDCO GERMANY AG INTENDS TO IMPLEMENT A MERGER
SQUEEZE-OUT OF MORPHOSYS AG’S MINORITY SHAREHOLDERS
* NOVARTIS BIDCO GERMANY AG CONFIRMED THAT IT CURRENTLY
HOLDS
APPROXIMATELY 91.04% OF TOTAL MORPHOSYS AG SHARE CAPITAL
* AMOUNT OF ADEQUATE CASH COMPENSATION THAT NOVARTIS BIDCO
GERMANY
AG, WILL GRANT TO MORPHOSYS AG'S MINORITY SHAREHOLDERS FOR
TRANSFER OF THEIR SHARES HAS NOT YET BEEN DETERMINED
* NECESSARY SHAREHOLDERS' RESOLUTION ON MERGER SQUEEZE-OUT
AT
MORPHOSYS AG ANNUAL GENERAL MEETING EXPECTED TO TAKE PLACE IN
AUGUST 2024
Source text for Eikon: ID:nEQbYmWH2a
Further company coverage: MORG.DE
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 778 51 10;))
Recent news on Morphosys AG
See all newsBrief: Morphosys Announces Voluntary Delisting From The Nasdaq Global Market
Brief: Morphosys Says Merger Squeeze-Out Cash Compensation Determined At Eur 68.00
Brief: Morphosys And Novartis Sign Delisting Agreement
Brief: Novartis BidCo Germany plans merger squeeze-out of Morphosys minority shareholders
Brief: Morphosys: Pichota and Lukas Gilgen replacing CEO And CFO